Your well-beingLearning from breast cancer survivors

Active survivorship centers on empowerment — on taking charge and learning all you can about breast cancer. We talked to 20 breast cancer patients about their experiences with active survivorship. Listen to the stories and diverse opinions of these amazing women. Gain insights. Get inspired. Then pass it on!

Leading Ladies module

Getting started is easy. Click any woman's photo to hear her address a variety of topics. Or choose a topic from the pull-down menu to hear insights from several different Leading Ladies.

  • Make sure your speakers are turned on
  • Click on the “Launch Leading Ladies” button below
  • Once the module opens, there are two ways to hear each Leading Lady's insights
    • Choose a topic in the pull-down menu on the upper right, or
    • Click on any woman's photo
  • Adjust the volume and pause or restart the video using the controls at the bottom of the module
LAUNCH LEADING LADIES

To view the video, you need Adobe® Flash® Player installed. If you do not have Adobe Flash Player on your computer, you can download it here.

Adobe Flash Player is a registered trademark of Adobe Systems Incorporated.

To view Leading Ladies, you will need Flash Player 8.0 or later. Download Flash.

Like what you heard? Watch as the Leading Ladies meet for the first time.

To view the download, you need Adobe® Acrobat® Reader® installed. If you do not have Adobe Acrobat Reader on your computer, you can download it from the Adobe Web site.

Adobe Acrobat Reader is a registered trademark of Adobe Systems Incorporated.

Important Information About ARIMIDEX

ARIMIDEX is approved for adjuvant treatment (treatment following surgery with or without radiation) of postmenopausal women with hormone receptor-positive early breast cancer.

ARIMIDEX is approved for the initial treatment of postmenopausal women with hormone receptor-positive or hormone receptor-unknown locally advanced or metastatic breast cancer and for the treatment of postmenopausal women with advanced breast cancer that has progressed following treatment with tamoxifen. Patients with hormone receptor-negative disease and patients who did not previously respond to tamoxifen therapy rarely responded to ARIMIDEX.

Important Safety Information About ARIMIDEX

  • Prescription ARIMIDEX is only for postmenopausal women. ARIMIDEX should not be taken if you are pregnant because it may harm your unborn child
  • Based on information from a study in patients with early breast cancer, women with a history of blockages in heart arteries (ischemic heart disease) who take ARIMIDEX may have a slight increase in this type of heart disease compared to similar patients who take tamoxifen
  • ARIMIDEX can cause bone softening/weakening (osteoporosis) increasing the chance of fractures. In a clinical study in early breast cancer, there were more fractures (including fractures of the spine, hip, and wrist) with ARIMIDEX (10%) than with tamoxifen (7%)
  • In a clinical study in early breast cancer, some patients taking ARIMIDEX had an increase in cholesterol. Skin reactions, allergic reactions, and changes in blood tests of liver function have also been reported
  • In the early breast cancer clinical trial, the most common side effects seen with ARIMIDEX include hot flashes, joint symptoms (including arthritis and arthralgia), weakness, mood changes, pain, back pain, sore throat, nausea and vomiting, rash, depression, high blood pressure, osteoporosis, fractures, swelling of arms/legs, insomnia, and headache
  • In advanced breast cancer trials, the most common side effects seen with ARIMIDEX versus tamoxifen include hot flashes, nausea, decreased energy and weakness, pain, back pain, headache, bone pain, increased cough, shortness of breath, sore throat, and swelling of arms and legs. Joint pain/stiffness has been reported in association with the use of ARIMIDEX
  • ARIMIDEX should not be taken with tamoxifen or estrogen-containing therapies

Please click here for full Prescribing Information.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088 (1-800-332-1088).